This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Mark J Smyth: Innovator in Serine Protease Research
Introduction
Mark J Smyth is a notable inventor based in Lower Plenty, Australia. He has made significant contributions to the field of biochemistry, particularly in the area of serine proteases. His work has implications for various applications in health and disease management.
Latest Patents
Mark J Smyth holds a patent for a purified and isolated nucleic acid molecule encoding serine protease, known as Met-ase. This invention is characterized by its Met-ase activity without Asp-ase activity and has a molecular weight of approximately 30,000 daltons on SDS PAGE under both reducing and non-reducing conditions. The patent also includes a vector comprising this nucleic acid molecule and a method for detecting this nucleic acid in a sample.
Career Highlights
Mark J Smyth is associated with the United States of America as represented by the Department of Health. His work in this capacity has allowed him to collaborate with leading experts in the field and contribute to advancements in protease research.
Collaborations
Some of his notable coworkers include Thomas Sayers and Theresa A Wiltrout. Their collaborative efforts have furthered the understanding and application of serine proteases in various scientific domains.
Conclusion
Mark J Smyth's innovative work in serine protease research exemplifies the impact of dedicated inventors in the scientific community. His contributions continue to influence the field and pave the way for future advancements.